Skip to main content
logo
Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.340
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Calidi Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-19.91-22.14-29.22-25.43-10.93
Depreciation & Amortization
1.651.541.260.260.16
Other Amortization
-0.050.430.120.56
Loss (Gain) From Sale of Assets
-0.24-0.01--
Asset Writedown & Restructuring Costs
----0.17
Stock-Based Compensation
2.112.964.814.521.33
Other Operating Activities
-0.16-0.391.973.74-0.15
Change in Accounts Payable
-1.33-0.63-6.171.62-0.24
Change in Other Net Operating Assets
-3.42-1.07-0.071.951.34
Operating Cash Flow
-21.29-19.69-26.98-13.21-7.77
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.12-0.02-0.59-0.43-0.21
Cash Acquisitions
--0.01--
Divestitures
-0.05----
Other Investing Activities
--0.1-0.07-0.01
Investing Cash Flow
-0.17-0.02-0.48-0.49-0.22

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.23.251.51.5
Long-Term Debt Issued
-3.6--0.38
Total Debt Issued
-3.83.251.51.88
Short-Term Debt Repaid
-0.4-0.3-1.3-0.04-0.1
Long-Term Debt Repaid
-2.09-1.58-1.05-0.08-0.03
Total Debt Repaid
-2.49-1.88-2.35-0.12-0.13
Net Debt Issued (Repaid)
-2.491.920.91.381.75
Issuance of Common Stock
16.6622.870.280.110.14
Other Financing Activities
3.292.583.3710.597.93
Financing Cash Flow
17.4627.3729.0412.099.81

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.01-0.01-0.01-0.03-0
Net Cash Flow
-3.997.641.58-1.651.82

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-21.41-19.71-27.57-13.64-7.98
Free Cash Flow Growth
-----
Free Cash Flow Margin
----30315.56%-1777.28%
Free Cash Flow Per Share
-79.64-472.80---775.89
Levered Free Cash Flow
-11.85-11.65-43.966.7412.15
Unlevered Free Cash Flow
-11.66-10.68-43.726.7211.97

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.270.140.40.040.05
Cash Income Tax Paid
0.020.010.010.010.01
Change in Working Capital
-4.74-1.7-6.243.571.1
SEC Filings: 10-K · 10-Q